digitalbiopharma

In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture’s Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future.

In Episode 11, host Tom Lehmann and guest Julie Huxley-Jones, GSK, discuss the mindset of scientific curiosity, innovation and collaboration and its role on the impact of digital in scientific discovery. They talk about the unique journey of digital in discovery research and how it’s increasing productivity and innovation.

Tom Lehmann talks with Stephen Davies, VP, Eisai Enterprise Information Technology about Eisai’s human health care philosophy. It’s guiding innovation, shaping digital transformation and encouraging a holistic health care view by leveraging technology beyond traditional therapeutics.

Host Tom Lehmann talks with John Kelleher, head of digital quality for Pfizer global supply. John shares insights on connecting learnings and impacts of a digital QA transformation pilot to a more holistic QC transformation initiative.

Debraj Dasgupta talks with Tom Lehmann about the building blocks and historic obstacles to a successful digital transformation in biopharma.

Host Tom Lehmann talks with Kailash Swarna, global head of R&D digitalization strategy at NovoNordisk about data complexity, measuring digital value, keeping pace with the next generation of science and patient centricity.

In this premier episode of our new podcast series, host Tom Lehmann explores findings from our report on Digitalization in Biopharma R&D with one of the co-authors, Katie Miinch. Together, they unpack key insights and what the findings mean for companies today and into the future.